In a 2021 pilot study of acute ischemic stroke patients receiving thrombolysis, researchers measured baseline AQP4 in blood and found an inverse correlation with infarct size and NIH stroke scale scores; paradoxically, patients with higher serum AQP4 had better early neurological improvement and outcomes [48]. The gene discussed is AQP4; the disease is infarction.